Showing 1071-1080 of 1560 results for "".
- New Method Tracks How Psychedelics Affect Neurons in Minuteshttps://reachmd.com/news/new-method-tracks-how-psychedelics-affect-neurons-in-minutes/2467682/Mouse neurons treated with the new CaST labeling technique developed at UC Davis. CaST enables rapid labeling of brain cells as they respond to psychedelic drugs such as psilocybin or LSD
- Immunology Research Finds New Immune Disease Targethttps://reachmd.com/news/immunology-research-finds-new-immune-disease-target/2467619/A medical mystery inspired a Yale-led study with potential treatments for autoimmune diseases. A young girl had blood cell issues, breathing problems, and diarrhea, along with low antibody levels and recurrent
- Study: Crotoxin Demonstrates Efficacy Against Melanoma with Reduced Toxicityhttps://reachmd.com/news/crotoxin-demonstrates-efficacy-against-melanoma-reduced-toxicity/2467490/A new study in Frontiers in Pharmacology indicated that crotoxin (CTX), a component of snake venom, was associated with antiproliferative effects on melanoma cells. "Melanoma, a highly aggressive skin cancer originating in melanocytes, poses a significant threat due to its metast
- Deep and Durable Responses: Ide-Cel CAR T Shows Promise for High-Risk Multiple Myeloma Relapsehttps://reachmd.com/news/deep-and-durable-responses-ide-cel-car-t-shows-promise-for-high-risk-multiple-myeloma-relapse/2467348/Bone marrow aspirate cytology of multiple myeloma: ©David A Litman - stock.adobe.comTreatment with the chimeric antigen receptor (CAR) T-cell therapy idecabtagene vicleucel (ide-cel; Abecma) demonstrated frequeny, durable responses when
- New Molecular Signatures Found for Alzheimer’s Diseasehttps://reachmd.com/news/new-molecular-signatures-found-for-alzheimers-disease/2467273/Summary: Researchers identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer’s disease. They discovered altered communication between brain vascular cells mediated by VEGFA and SMAD3 molecules. These findings could lead to new diagnost
- Immune Response Study Explains Why Some People Don’t Get COVID-19https://reachmd.com/news/immune-response-study-explains-why-some-people-dont-get-covid-19/2467110/Using single-cell sequencing technology, researchers provide the most comprehensive timeline to date of how the body responds to SARS-CoV-2 exposure. Email newsletter News and blog u
- Discovery of ‘New Rules of the Immune System’ Could Improve Treatment of Inflammatory Diseases, Say Scientistshttps://reachmd.com/news/discovery-of-new-rules-of-the-immune-system-could-improve-treatment-of-inflammatory-diseases-say-scientists/2467091/This overturns the traditional thinking that regulatory T cells exist as multiple specialist populations that are restricted to specific parts of the body. The finding has implications for the treatment of many different diseases – because almost all diseases and injuries trigger the bo
- Repurposed Drug May Help Stabilize Vision in Rare Diseasehttps://reachmd.com/news/repurposed-drug-may-help-stabilize-vision-in-rare-disease/2467084/Visit the News Hub Repurposed drug may help stabilize vision in rare diseaseClinical trial for RVCL-S patients tests drug already approved as sickle cell disease treatmentMatt Mil
- A Deep Dive on Inflammatory Pain Could Open Up New Solutionshttps://reachmd.com/news/a-deep-dive-on-inflammatory-pain-could-open-up-new-solutions/2467055/A new study reveals thousands of molecular interactions between pain-sensing neurons and different types of immune cells. (Images: Adobe Stock | Illustration: Sebastian Stankiewicz, Boston Children’s Hospital)
- A New Way to See Viruses in Action: Super-Resolution Microscopy Provides a Nano-Scale Lookhttps://reachmd.com/news/a-new-way-to-see-viruses-in-action-super-resolution-microscopy-provides-a-nano-scale-look/2466920/Viral RNA, labeled with a fluorescent dye, clusters around the nucleus of a cell infected with SARS-CoV-2, as captured through super-resolution microscopy. Credit: Nature Communica